| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 05/12/2004 | CN1149081C Arylsubstituted piperazines useful in the threatement of bening prostatic hyperlasia |
| 05/11/2004 | CA2156481C 5-ht2 receptor antagonist compositions useful in treating venous conditions |
| 05/06/2004 | WO2004037853A2 Quinolones with anti-hiv activity |
| 05/06/2004 | WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands |
| 05/06/2004 | WO2004037792A2 Benzo (f) quinolinone variants as nuclear hormone receptor ligands |
| 05/06/2004 | EP1416017A1 Fluorescent nucleosides, nucleotides or polynucleotides containing a rhodamine dye |
| 05/06/2004 | EP1414795A1 Bicyclic modulators of androgen receptor function |
| 05/06/2004 | EP1414457A1 Chiral dinapsoline |
| 05/05/2004 | CN1494422A Use of GABAA inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin E for treatment of cognitive disorders |
| 05/04/2004 | CA2119756C Process for preparing benzo[b]naphtyridines |
| 04/29/2004 | US20040082788 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
| 04/29/2004 | US20040082783 Bis (amino acid) molecular scaffolds |
| 04/29/2004 | US20040082619 Pyridone derivatives having affinity for cannabinoid 2-type receptor |
| 04/29/2004 | US20040082592 Metabotropic glutamate receptor antagonists |
| 04/29/2004 | US20040082578 Antiinflammatory agents; Aids therapy; phosphodiesterase inhibitor |
| 04/29/2004 | US20040082555 Use of gaba, inverse agonists in combination with nicotine receptor partial agonist, estrogen, selective estrogen modulators, or vitamin E for the treatment of cognitive disorders |
| 04/28/2004 | EP1411947A2 Salts of substituted 1, 2, 3, 4-tetrahydroisoquinoline-2-carboxylic acid derivatives |
| 04/28/2004 | CN1492858A Pylene derivatives and their use as dyes |
| 04/28/2004 | CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 04/28/2004 | CN1147493C Oxazolo, thiazole and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof and pharmaceutical composition containing them |
| 04/27/2004 | US6727318 Method for producing aqueous polymer dispersions containing colorants |
| 04/27/2004 | US6727256 4-aminoquinazoline derivatives as anticarcinogenic agents |
| 04/27/2004 | US6726972 Optical data storage medium containing a diaza hemicyanine dye as the light-absorbing compound in the information layer |
| 04/27/2004 | CA2104214C Cytokine inhibitors |
| 04/22/2004 | WO2004018431A3 Novel phenanthridines |
| 04/22/2004 | US20040077879 Building blocks linked together through the formation of rigid diketopiperazine rings |
| 04/22/2004 | US20040077673 Forms of dutasteride and methods for preparation thereof |
| 04/22/2004 | US20040077643 3,4 Dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 04/21/2004 | EP1411047A1 Intercalators having affinity for DNA and methods of use |
| 04/21/2004 | EP1408960A1 Benz-indole and benzo-quinoline derivatives as prodrugs for tumour treatment |
| 04/21/2004 | EP0904262B1 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| 04/20/2004 | US6723733 Polymerase inhibitor |
| 04/15/2004 | WO2004031153A2 Enantioselective alkylation of tricyclic compounds |
| 04/15/2004 | US20040072209 Methods of labelling polynucleotides with dibenzorhodamine dyes |
| 04/15/2004 | CA2501292A1 Enantioselective alkylation of tricyclic compounds |
| 04/14/2004 | EP1408090A1 Dibenzorhodamine dyes useful as fluorescent labelling agents |
| 04/14/2004 | EP1296955B1 Process for the manufacture of 1,8-naphthalimide |
| 04/14/2004 | EP1171440B1 Substituted-3-cyano-[1.7],[1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases |
| 04/14/2004 | EP1115708B1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 04/14/2004 | EP1054907B1 Method for producing aqueous polymer dispersions containing colorants |
| 04/14/2004 | EP1040097B1 Potassium channel openers |
| 04/14/2004 | EP0706515B1 Intercalators having affinity for dna and methods of use |
| 04/13/2004 | US6720338 Bcl-x1 inhibiting compositions and methods of promoting apoptosis in a mammal |
| 04/08/2004 | WO2004029028A2 9-cyano-substituted perylene-3,4-dicarboxylic acid monoimides as dyestuffs |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003070690A3 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 04/08/2004 | US20040068114 Rylene derivatives |
| 04/08/2004 | US20040067972 Acetylcholinesterase inhibitor; Alzheimer's disease; cognition activators; central nervous system disorders |
| 04/07/2004 | CN1144805C Bridged bispidine compounds, its preparing method and intermediate and use for treatment of cardiac arrhythmias |
| 04/07/2004 | CN1144787C Aryl fused azapolycyclic compounds |
| 04/06/2004 | CA2293672C Tricyclic keto amide derivatives useful as farnesyl protein transferase inhibitors |
| 04/06/2004 | CA2284646C Synthesis of intermediates useful in preparing tricyclic compounds |
| 04/01/2004 | WO2004026859A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2003099819A3 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 04/01/2004 | WO2003066597A3 Guanidino compounds |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063942 Spiro-indolines as Y5 receptor antagonists |
| 04/01/2004 | US20040063753 N-acetoamino-4-one-Pyridine derivatives are used as Lp-PLA2 (lipoprotein Associated Phospholipase A2) enzyme inhibitor |
| 04/01/2004 | US20040063741 Dopamine receptor agonist for treatment of movement disorders/Parkinson's disease |
| 04/01/2004 | US20040063736 Combination of active ingredients containing alfuzosine and apomorphine |
| 04/01/2004 | DE10243906A1 9-Cyanosubstituierte Perylen-3,4-dicarbonsäuremonoimide 9-cyano-substituted perylene-3,4-dicarboxylic monoimides |
| 03/31/2004 | EP1401439A1 Use of bicyclo compounds for treating alzheimer's disease |
| 03/31/2004 | CN1486183A Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 03/31/2004 | CN1143675C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 03/30/2004 | US6713622 Contacting a 4,7-dichlororhodamine dye comprising a linking group with a polynucleotide comprising a terminal functionality complementary to the linking group |
| 03/30/2004 | US6713485 Antiproliferative agents; side effect reduction |
| 03/30/2004 | US6713471 Such as tert-butyl-1-methyl-6,7,9,12-tetrahydro-5h-pyrido-(4,3-b)(1,4) thiazepino(2,3,4-hi)indole-11(10h)-carboxylate; serotonin agonists and antagonists; central nervous system disorders |
| 03/30/2004 | US6713146 Singly recordable compact disc (cd-r) |
| 03/30/2004 | CA2217499C Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 03/25/2004 | WO2004024728A2 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 03/25/2004 | WO2004024702A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 03/25/2004 | WO2004024696A1 Purification method for fredericamycin a |
| 03/25/2004 | WO2004024695A1 Novel molecules derived from noraporphine |
| 03/25/2004 | US20040059145 Heterodiamondoids |
| 03/25/2004 | CA2498532A1 Antidepressant piperidine derivatives of heterocycle-fused benzodioxans |
| 03/25/2004 | CA2497550A1 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 03/25/2004 | CA2496563A1 New carboxamide compounds having mch-antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture |
| 03/24/2004 | EP1400514A1 Metal coordination compound and electroluminescence device |
| 03/24/2004 | EP1399445A2 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 03/24/2004 | CN1142914C New phenanthridines |
| 03/18/2004 | WO2004022542A2 Substituted 1,2,3,4-tetrahydroquinoline derivatives |
| 03/18/2004 | WO2003097608A3 Opioid and opioid-like compounds and uses thereof |
| 03/18/2004 | US20040053964 N-type calcium channel antagonists for the treatment of pain |
| 03/18/2004 | US20040053931 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 03/18/2004 | US20040053920 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
| 03/17/2004 | EP1397360A1 Azaindoles |
| 03/17/2004 | EP1140936B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/17/2004 | CN1483019A Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 03/16/2004 | US6706855 Antimicrobial polymer |
| 03/16/2004 | US6706716 Compounds specific for the human α1d adrenergic receptor and uses thereof |
| 03/16/2004 | US6706702 For therapy of neurological and psychological disorders |
| 03/11/2004 | WO2004019945A1 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| 03/11/2004 | WO2004019944A1 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| 03/11/2004 | US20040049030 Such as naphthalenes, anthracenes, phenanthrenes, tetracenes, perylenes, terrylenes, quaterrylenes, pentarylenes, hexarylenes, anthraquinones, indanthrones, and N-substituted naphthalene-1,8-dicarboxylic monoimides |
| 03/11/2004 | US20040045102 Preparation of dyed plastics or polymeric dye particles |
| 03/11/2004 | DE10239078A1 Recovery of pure fredericamycin A, for use as antitumor antibiotic, including concentration by precipitation from acidic solution with non-polar solvent, preferably cyclohexane |
| 03/11/2004 | DE10238865A1 New carboxamides are melanin-concentrating hormone receptor antagonists, useful for treating e.g. metabolic diseases, diabetes, eating disorders, cardiovascular disease, emotional disorders, reproductive and memory disorders |
| 03/11/2004 | DE10236910A1 Substituierte 1,2,3,4-Tetrahydrochinolinderivate Substituted 1,2,3,4-tetrahydroquinoline |
| 03/11/2004 | CA2496459A1 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| 03/10/2004 | EP1396493A1 Heterocyclic compounds |